您好,欢迎来到上海墨芊生物科技有限公司!

联系电话:

021-54477273

当前位置:首页>产品中心>细胞生物学>ab251500 ; Anti-Anterior Gradient 2 antibody [EPR20164-278] - BSA and Azide free ; 100ug

ab251500 ; Anti-Anterior Gradient 2 antibody [EPR20164-278] - BSA and Azide free ; 100ug

  • 价格:¥10,677.00 元

产品介绍

    产品名称
    Anti-Anterior Gradient 2抗体[EPR20164-278] - BSA and Azide free
    参阅全部 Anterior Gradient 2 一抗
    描述
    兔单克隆抗体[EPR20164-278] to Anterior Gradient 2 - BSA and Azide free
    宿主
    Rabbit
    经测试应用
    适用于: WB, IHC-P, Flow Cyt (Intra), ICC/IFmore details
    种属反应性
    与反应: Mouse, Rat, Human, Recombinant fragment
    免疫原
    Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.

    常规说明
    ab251500 is the carrier-free version of ab209224.

    Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.

    This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

    Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with <1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

    This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    - High batch-to-batch consistency and reproducibility
    - Improved sensitivity and specificity
    - Long-term security of supply
    - Animal-free production
    For more information see here.
    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.